Visceral leishmaniasis: rapid response to AmBisome treatment.
- 1 August 1995
- journal article
- case report
- Published by BMJ in Archives of Disease in Childhood
- Vol. 73 (2) , 157-159
- https://doi.org/10.1136/adc.73.2.157
Abstract
There appears to be an increase in imported cases of visceral leishmaniasis in Northern Europe; many are children infected on holiday in the Mediterranean. Making the diagnosis in young children can be difficult especially when an adequate travel history is not obtained at presentation. Two infants with visceral leishmaniasis are presented who were initially felt to have alternative diagnoses and who subsequently responded dramatically to a short course of liposomal amphotericin B (AmBisome).Keywords
This publication has 9 references indexed in Scilit:
- Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azarThe Lancet, 1994
- Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trialQJM: An International Journal of Medicine, 1994
- Activity of Liposomal Amphotericin B (AmBisome) AgainstLeishmania infantumand Tissue Distribution in MiceJournal of Drug Targeting, 1993
- Visceral leishmaniasis in the Sudan: comparative parasitological methods of diagnosisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1988
- Selective Primary Health Care: Strategies for Control of Disease in the Developing World. XIV. LeishmaniasisClinical Infectious Diseases, 1984
- Splenic aspiration. Review of the literature.1983